Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity

This study aimed to explore predictors of long-term stabilization of polypoidal choroidal vasculopathy (PCV) lesions and vision in response to injection of intravitreal ranibizumab (IVR). The treated eyes had a baseline best corrected visual acuity (BCVA) of at least 0.6 (logarithm of the minimal an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Ryusaburo, Tanaka, Koji, Yuzawa, Mitsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024465/
https://www.ncbi.nlm.nih.gov/pubmed/29924037
http://dx.doi.org/10.1097/MD.0000000000011188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024465/
https://www.ncbi.nlm.nih.gov/pubmed/29924037
http://dx.doi.org/10.1097/MD.0000000000011188

Ejemplares similares